𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance

✍ Scribed by Hagop Kantarjian; Phillipp le Coutre; Jorge Cortes; Javier Pinilla-Ibarz; Arnon Nagler; Andreas Hochhaus; Shinya Kimura; Oliver Ottmann


Book ID
102109641
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
226 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.